logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Changfeng Pharmaceutical (02652.HK) spent approximately HK$651,500 on May 19 to repurchase 32,000 shares.

date
19/05/2026
Smart Finance News APP reported that Changfeng Pharmaceutical (02652.HK) announced on May 19, 2026 that it spent approximately HK$651,500 to repurchase 32,000 shares.
Latest
1 m ago
Yifan Transmission: Intends to acquire 40% equity of Beijing Heli Times Electric Motor Technology Co., Ltd. for approximately 84 million RMB. The core products of the latter are mainly servo systems.
1 m ago
Nongfu Spring (09633) appoints Zhong Shangshang as Chairman.
2 m ago
The CEO of Shell stated that the acquisition of ARC is not dependent on the progression of the second phase of the Canadian liquefied natural gas project.
2 m ago
Hansett Eye Tai-B (03378.HK) spent HK$784,000 to repurchase 26,500 shares on May 19th.
3 m ago
French Finance Minister Le Maire: We are firmly committed to maintaining and continuing sanctions against Russia.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.